Aktualności 2014

Monografie:

1. Orzechowska A., Gałecki P. (red.). Zaburzenia psychosomatyczne w ujęciu terapeutycznym. Wrocław,  Continuo, 2014, ISBN: 978-83-62182-37-4.
2. Eichstaedt K., Gałecki P., Depko A. Metodyka pracy biegłego psychiatry, psychologa i seksuologa w sprawach karnych oraz wykroczeń. Warszawa, LexisNexis, 2014, ISBN: 978-83-278-0625-3.

Artykuły w czasopismach:

1. Talarowska M., Szemraj J., Zajączkowska M., Gałecki P. ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder. Med Sci Monit. 2014;20:905-12. doi: 10.12659/MSM.890160.
2. Gałecki P., Talarowska M., Bobińska K., Szemraj J. COX-2 gene expression is correlated with cognitive function in recurrent depressive disorder. Psychiatry Res. 2014;215(2):488-90. doi: 10.1016/j.psychres.2013.12.017.
3. Talarowska M., Bobińska K., Zajączkowska M., Su KP., Maes M., Gałecki P. Impact of oxidative/nitrosative stress and inflammation on cognitive functions in patients with recurrent depressive disorders. Med Sci Monit. 2014;20:110-5. doi: 10.12659/MSM.889853.
4. Talarowska M., Orzechowska A., Szemraj J., Su K.P., Maes M., Gałecki P. Manganese superoxide dismutase gene expression and cognitive functions in recurrent depressive disorder. Neuropsychobiology. 2014;70(1):23-8. doi: 10.1159/000363340.
5. Morris G., Berk M., Galecki P., Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs). Mol Neurobiol. 2014;49(2):741-56. doi: 10.1007/s12035-013-8553-0.
6. Morris G., Anderson G., Dean O., Berk M., Galecki P., Martin-Subero M., Maes M. The glutathione system: a new drug target in neuroimmune disorders. Mol Neurobiol. 2014;50(3):1059-84. doi: 10.1007/s12035-014-8705-x.
7. Berent D., Zboralski K., Orzechowska A., Gałecki P. Thyroid hormones association with depression severity and clinical outcome in patients with major depressive disorder. Mol Biol Rep. 2014;41(4):2419-25. doi: 10.1007/s11033-014-3097-6.
8. Berent D., Macander M., Szemraj J., Orzechowska A., Galecki P. Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins. Acta Neurobiol Exp (Wars). 2014;74(1):82-90.